Full Text
HTA224 Commissioning Through Evaluation: RWE for Rituximab in the Management of Idiopathic Membranous Nephropathy

Abstract

Authors

H Patrick KH Bui M Grzeda S Norton C Austin A Barnes D Kanigicherla A Khwaja

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×